Search Results - J. Mort
- Showing 1 - 2 results of 2
-
1
P526: REAL-WORLD COMPARISON OF DIFFERENT TREATMENT MODALITIES FOR FAVORABLE RISK ACUTE MYELOID LEUKEMIA: STANDARD DOSE ANTHRACYCLINE VS HIGH DOSE ANTHRACYCLINE VS ADDITION OF GEMTU... by J. Mort, B. Brewer, B. Mautner, S. Dibenedetto, E. Pierce, E. Morse, L. Wells, F. Ghamsari, A. Morris, S. Clark, J. Reid, I. Patel, C. Jackson, M. Perciavalle, B. Yelvington, R. Miller, K. Abernathy, H. Wolfe, S. Locke, J. Zeidner, D. Reed, V. Duong, B. Dholaria, T. LeBlanc, M. Keng, B. Horton, F. El Chaer
Published in HemaSphere (2022-06-01)Get full text
Article -
2
P354: REAL-WORLD ANALYSIS OF THE RISKS OF THROMBOTIC AND BLEEDING EVENTS IN PATIENTS RECEIVING PEGYLATED ASPARAGINASE FOR TREATMENT OF ACUTE LYMPHOBLASTIC LEUKEMIA by B. Mautner, B. Brewer, J. Mort, E. Pierce, F. Ghamsari, S. Dibenedetto, E. Morse, L. Wells, A. Morris, C. Allen, I. Patel, D. D’Souza, C. Jackson, M. Perciavalle, B. Yelvington, R. Miller, K. Abernathy, K. Walsh, H. Wolfe, S. Locke, D. Reed, V. Duong, B. Dholaria, T. LeBlanc, R. Shallis, M. Keng, B. Horton, F. El Chaer
Published in HemaSphere (2022-06-01)Get full text
Article
